Biotech Sector CatalystsFour Oncology Drugs Face FDA PDUFA Decisions in 2026, Stacking Binary Catalyst Risk Into a Narrow WindowSalvado•Jun 19, 2026
Earnings & Corporate EventsCardiff Oncology CEO Faces FDA Trial Endpoint Risk as Q1 Data NearsViaNews Editorial Team (Markets)•Mar 7, 2026
